Technetium(V) and rhenium(V) complexes for 5-HT(2A) serotonin receptor binding: Structure-affinity considerations

Nuclear Medicine and Biology

Volumn 23, Issue 4, 1996, Pages 429-438

  Johannsen, B ^a   Scheunemann, M ^a   Spies, H ^a   Brust, P ^a   Wober, J ^a   Syhre, R ^a   Pietzsch, H J ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Biodistribution; Ketanserin; Re complexes; Serotonin receptor binding; Tc complexes

Indexed keywords

KETANSERIN; RHENIUM; SEROTONIN ANTAGONIST; TECHNETIUM 99M; TECHNETIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; PHARMACOKINETICS; RAT;

EID: 0030152863     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00015-7     Document Type: Article

References (39)

1. 2 receptors. J. Med Chem. 37, 950-962.
2. 2. Baidoo K. E., Scheffel U., Lever S. Z., Stathis M., and Wagner H. N. (1995) Serotonin-1A receptor binding technetium-99m-labelled complexes. J. Nucl. Med. 36, 28P (Abstract).
3. 2 receptors antagonist. J. Cereb. Blood Flow Metab. 5, 471-476.
4. 2 antagonist. J. Lab. Compd. Radiopharm. 20, 73-78.
5. 5. Chi D. Y., Neil J. P. O., Anderson C. J., Welch M. J. and Katzenellenbogen J. A. (1994) Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium (V): Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J. Med. Chem. 37, 928-937.
6. 18F]setoperone. J. Lab. Compd. Radiopharm. 25, 403-414.
7. 7. Crouzel C., Guillaume M., Barré L., Lemaire C. and Pike V. W. (1992) Ligands and tracers for PET studies of the 5-HT system - current status. Nucl. Med. Biol. 19, 857-870.
8. 99m/99Tc-DADT-benzovesamicol: A potential marker for cholinergic neurons. Nucl. Med. Biol. 21, 197-203.
9. 9. Eckelman W. C. (1995) Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems. Eur J. Nucl. Med. 22, 249-263.
10. 2 receptor. Mol. Brain Res. 14, 166-178.
11. 11. Eison A. E. and Eison M. S. (1994) Serotonergic mechanisms in anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 18, 47-62.
12. 12. Fietz T., Spies H., Pietzsch H.-J. and P. Leibnitz (1995) Synthesis and crystal structure of (3-thiapentane-1.5-dithiolato)chlorooxorhenium(V). Inorg. Chim. Acta 231, 233-236.
13. 13. Hansch C. (Ed.) (1990) In Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds. Vol 6: Cumulative Subject Index and Drug Compendium. Pergamon Press, Oxford.
14. 1C serotonin receptor binding. J. Med. Chem. 35, 4903-4910.
15. 15. Johannsen B., Spies H. and Syhre R. (1978) meso-und rac.-2,3-Dimercaptosuccinatotechnetat(V). Radiochem. Radioanal. Lett. 36, 111-116.
16. 16. Johannsen B., Pietzsch H.-J., Scheunemann M., Spies H. and P. Brust (1995) Oxotechnetium(V) and oxorhenium(V) complexes as potential imaging agents for the serotonin receptor. J. Nucl. Med. 36, 27P (Abstract).
17. 17. Jurisson S. S., Pirro J., DiRocco R. J., Rosenspire K. C., Jagoda E., Nanjappan P., Eckelman W. C., Nowotnik D. P. and Nunn A. D. (1995) Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: Syntheses and studies of their binding to the muscatinic acetylcholine receptor. Nucl. Biol. Med. 22, 269-281.
18. 2 receptor. Med. Chem. Res. 3, 370-385.
19. 1A receptor imaging agents. In Technetium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bendoli G. and Mazzi U.), pp. 293-298. SGEditoriali, Padua.
20. 20. Kusumi I., Koyama T. and Yamashita I. (1994) Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology 113, 322-327.
21. 18F]Altanserin, a potential radioligand for the study of serotonin receptors: Radiolabeling and in vivo biological behaviour in rats. J. Nucl. Med. 32, 2266-2272.
22. 22. Lever S. Z. and Wagner Jr. H. N. (1989) The status and future of technetium-99m radiopharmaceuticals. In Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicolino M., Bandoli G. and Mazziu U.), pp. 649-659. Cortina Intern, Verona.
23. 23. Lever S. Z., Baidoo K. E., Mohamood A., Matsumura K., Scheffel U. and Wagner H. N. (1994) Novel technetium ligands with affinity for the muscarinic cholinergic receptor. Nucl. Med. Biol. 21, 157-164.
24. 24. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
25. 2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol. Psychiatry 35, 295-308.
26. 125I]DOI, a new psychomimetic radioligand. Brain Res. 476, 45-56.
27. 2 receptor mapping with SPECT in baboon brain. J. Nucl. Med. 30, 741 (Absrract).
28. 28. Minick D. J., Frenz J. H., Patrick, M. A. and Brent D. A. (1988) A comprehensive method for determining hydrophobicity constants by reversed-phase high performance liquid chromatography. J. Med. Chem. 31, 1923-1933.
29. 29. Ohuoha D. C., Hyde T. M. and Kleinman J. E. (1993) The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psychopharmacology 112, S5-S15.
30. 30. Pietzsch H.-J., Spies H, and Hoffmann S. (1989) Lipophilic technetium complexes VI: Neutral oxotechnetium(V) complexes with monothiole/ tridentate dithiole coordination. Inorg. Chim. Acta 165, 163-166.
31. 2 receptor in senile dementia of the Alzheimer type. Neurosci. Lett. 44, 47-51.
32. 99mTc-BUP-BAT: Possible ligands for dopamine receptor imaging with SPECT. In Technetium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bandoli G. and Mazziu U.), pp. 293-298. SGEditoriali, Padua.
33. 33. Scheffel U., Goldfarb H. W., Lever S. Z., Gungon R. L., Burns H. D. and Wagner, Jr. H. N. (1988) Comparison of technetium-99m amino-alkyl diaminodithiol (DADT) analogs as potential brain blood flow imaging agents. J. Nucl. Med. 29, 73-82.
34. 34. Scheunemann M., Pietzsch H.-J., Spies H., Fietz T., Leibnitz P., Brust P., J. Wober and B. Johannsen (1996) Submitted for publication.
35. 125I]7-amino-8-iodo-ketanserin. Eur. J. Pharmacol. [Mol. Sect.] 172, 99-106.
36. 3 ligands. Angew. Chem. Intern. Ed. Engl. 33, 1354-1356.
37. 37. Spies H., Fietz Th., Glaser M., Pietzsch H.-J. and Johannsen B. (1995) The "n+1" Concept in the Synthesis Strategy of Novel Technetium and Rhenium Tracers. In Technetium in Chemistry and Nuclear medicine (Edited by Nicolini M., Bandoli G. and Mazzi U.), pp. 293-298. SGEditoriali, Padua.
38. 38. Spies H., Fietz Th., Pietzsch H.-J., Johannsen B., Leibnitz P., Reck G., Scheller D. and Klostermann K. (1995) Alkyl and aryl substituted oxorhenium(V) complexes with tridentate/monodentate coordination. J. Chem. Soc. Dalton Trans. 2277-2280.
39. 39. Spies H. and Johannsen B. (1995) Functionalization of technetium complexes to make them active in vivo. Analyst 120, 775-777.